News and Trends 2 Jul 2021
Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce
As French biotech Poxel marks the first market approval of its oral type 2 diabetes medication in Japan, eyes turn to the future of this drug and its rivals in Europe and the US. The fortunes of the Lyon-based Poxel have been boosted by the first-ever regulatory approval of its oral type 2 diabetes medication […]